Celgene Cellular Therapeutics
GPTKB entity
Statements (15)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:acquiredBy |
gptkb:Bristol_Myers_Squibb
|
| gptkbp:country |
gptkb:United_States
|
| gptkbp:focusesOn |
cellular therapies
regenerative medicine |
| https://www.w3.org/2000/01/rdf-schema#label |
Celgene Cellular Therapeutics
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:location |
gptkb:Warren,_New_Jersey,_United_States
|
| gptkbp:notableProduct |
PDA-001 (placental-derived stem cell therapy)
|
| gptkbp:parentCompany |
gptkb:Celgene_Corporation
|
| gptkbp:researchArea |
immunotherapy
stem cell therapy |
| gptkbp:subsidiary |
gptkb:Celgene_Corporation
|
| gptkbp:bfsParent |
gptkb:Robert_Harari
|
| gptkbp:bfsLayer |
7
|